2021
DOI: 10.1159/000514101
|View full text |Cite
|
Sign up to set email alerts
|

Cancer Stem Cell Markers in Squamous Cell Carcinomas of the Salivary Glands

Abstract: <b><i>Background:</i></b> Cancer stem cells (CSC) are cells that exhibit stem cell properties and are pivotal in tumor biology. CSC markers have been described for many tumorous entities. However, to this date, there is no data on CSC markers in respect to squamous cell carcinomas (SCC) of the salivary glands. <b><i>Methods:</i></b> Histologic samples from patients with salivary gland SCCs were stained for CSC markers (ALDH-1/BMI-1/SOX-2/CD-44/vimentin) and divid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…ALDH1 is associated with tumor malignancy and self-renewal properties of stem cells in HNCs ( 182 ) and has been associated with poorer prognosis and failure of chemoradiotherapy in HNCs ( 13 , 183 ). ALDH1 acts as a stem cell marker for HNCs such as oral cancer ( 184 ), eyelid sebaceous gland carcinoma ( 185 ), benign epithelial odontogenic lesions ( 186 ), salivary gland tumor ( 187 , 188 ), lip cancer ( 189 ), sublingual adenoma ( 190 ).…”
Section: Aldh1 and Various Solid Tumorsmentioning
confidence: 99%
“…ALDH1 is associated with tumor malignancy and self-renewal properties of stem cells in HNCs ( 182 ) and has been associated with poorer prognosis and failure of chemoradiotherapy in HNCs ( 13 , 183 ). ALDH1 acts as a stem cell marker for HNCs such as oral cancer ( 184 ), eyelid sebaceous gland carcinoma ( 185 ), benign epithelial odontogenic lesions ( 186 ), salivary gland tumor ( 187 , 188 ), lip cancer ( 189 ), sublingual adenoma ( 190 ).…”
Section: Aldh1 and Various Solid Tumorsmentioning
confidence: 99%
“…SCC de novo from the parotid gland reported only 0.3-6.9% of all parotid malignancies. In addition, SCC of the salivary glands is related to comparatively poor prognosis [3]. The diagnosis of parotid SCC depends on the exclusion of high grade mucoepidermoid carcinoma and metastatic SCC.…”
Section: Introductionmentioning
confidence: 99%